Uses of Withania somnifera (Linn) Dunal (Ashwagandha) in Ayurveda and its
Pharmacological Evidences
Dr. Sudhanshu Kumar Meher, Dr. Banmali Das, Dr. Purnendu Panda, Dr. G.C. Bhuyan,
Dr. M.M. Rao
National Research Institute
of Ayurvedic Drug Development, Bhubaneswar, Odisha
*Corresponding Author E-mail: drmeher@rediffmail.com
ABSTRACT:
Withania somnifera (Linn) Dunal
commonly known as Ashwagandha belongs to the family Solanaceae (nightshade family) which has got 1250 species
widely distributed in the warmer parts of the world. The genus Withania is reported to have 23 species and out of which Withania somnifera
(Linn) Dunal and Withania
coagulans Dunal are of
high medicinal value. Various preparations and forms of Withania
somnifera (Linn) Dunal
(Ashwagandha) i.e. powder, decoction, oil, smoke,
poultice etc. have been advised for the cure of various disorders such as skin
disorders, nervous disorders, intestinal affections, venereal diseases,
rheumatism, emaciation of children and as a tonic for all kinds of weakness and
in geriatrics. It also promotes vigor and stamina and is regarded as
aphrodisiac and rejuvenator. The plant is usually erect, branched, unarmed
shrub, up to 1.25 meters height and grows throughout the drier parts and
sub-tropical India. Mainly cultivated in Madhya Pradesh and Rajasthan and it
has huge internal consumption in India and also being exported. It is prone to
several pests and diseases which need to be take care during cultivation. Withaferin A and Withanolide D
are two main withanolides contribute to the most of
biological actions. It has pharmacological action in almost all systems of the
human body. It has also some side effects and contraindication. Number of
pharmacological studies have been conducted and a wide range of biological
activities have been observed such as anti inflammatory property, hepato-protective activity, infertility activity, anti
bacterial activity, psychotropic/anti anxiety activity, anti convulsant activity, skin care activity, healthy hair
activity, immune-modulator activity, anti peroxidative
action, anti ageing effect, macrophage activating effect, haemopoitic
effect, antibiotic activity, anti-tumour activity,
anti-hyperglycemic effect, morphine tolerance and dependence-inhibiting effect,
cardio tonic activity, hypo lipidemic, anti-atherogenic activity, positive inotropic
activity, hypoglycemic effect, anti-oxidant activity, anti-carcinogenic
activity etc. This review presents morphology of the plant, geographical
distribution, cultivation and market value, plant pathology, Ayurvedic properties, chemical ingredients, medicinal uses
in Ayurveda, side effects and contraindications,
pharmacological evidences of Withania somnifera (Linn) Dunal (Ashwagandha).
KEYWORDS: Ashwagandha, Withania somnifera (Linn) Dunal, Ayurveda, Pharmacological evidences
INTRODUCTION:
Since the early human existence, many natural products came into
practice for human welfare by sheer perception or by trial and error. Because
of this practice, in fact, every country including India, China, and Egypt
developed its own medical system. Thus the Indian Medical System-Ayurveda came into existence. Throughout human existence,
plants were virtually all that was available to healers. The raw materials used
for Ayurvedic medicines were dried herbal powders or
their extracts or mixtures of products. In today’s concept even though
synthetic products have taken a front seat, 25 to 30 percent of modern drugs
are derived from some parts of higher plants. In fact, botanical medicines have
made a comeback. Withania somnifera (Linn) Dunal (Ashwagandha) is an important drug in Indian system of
Medicine used widely by physicians as single as well as in combinations with
other drugs since time immemorial. It is commonly known as Ashwagandha
which belongs to the family Solanaceae (nightshade
family) which has got 1250 species widely distributed in the warmer parts of
the world. The genus Withania is reported to have 23
species and out of which Withania somnifera (Linn) Dunal and Withania coagulans Dunal are of high medicinal value. It is classified as a rasayana in Ayurveda and expected
to promote physical and mental health, restore the body and increase longevity.
It has been glorified over time for its dual capacity to energise
and calm at the same time. It is well known for its actions like Immunomodulator / Rasayan karma,
general tonic in arthritis, aphrodisiac, used in rheumatism, debility from old
age etc.
Synonyms
·
Physalis somnifera Linn.
·
Withania kansuensis Kuang and A. M. Lu
·
Withania microphysalis Suess.
Vernacular names:
Bengali- Ashwagandha
Eng.-Winter Cherry, Indian Ginseng
Gujarati-Asundha, Ghodaasoda
Hindi-Asgund, Panir
Malayalam-Amukkiram, Pevetti
Marathi-Asgund, Asvagandha
Odia-Aswagandha
Punjabi-Ak, Aksan, Asgund, Asgund Nagori, Isgand
Tamil-Amukkasi, Ashuhan
Telgu-Ashwagandha
Urdu-Asgandhu, Gaori
Morphology of the plant:
The plant is usually erect, branched, unarmed shrub, grows up to 1.25
meters height. The parts above the ground, specially the stem, the veins and
the calyx are covered with a sparsely hairy tomentum.
Branches are round. Leaves are simple, petiolate, ovate,
entire, exstipulate, acute, glabrose
and up to 10 cm long. The leaves on vegetative shoots are alternate, and large
while those on floral branches are opposite, arranges in pairs of one large and
one small leaf and somewhat laterally, having in their axil
a cymose cluster of 5 to 25 inconspicuous pale green
flowers. Fruit, a berry enclosed in the green persistent calyx, green when
unripe and orange red when mature containing numerous small capsicums like
seeds1.
Geographical Distribution:
Withania somnifera (Linn) Dunal grows
throughout the drier parts and sub-tropical India. It is widely distributed in
North-Western India, Bombay, Gujarat, Rajasthan, Madhya Pradesh, Uttar Pradesh,
Punjab plains extending to the mountain regions of Punjab, Himachal Pradesh and
Jammu, ascending to a height of 1500 meters. The wild growth of this species
has also been reported from Pakistan, Afghanistan, Israel, Egypt, Jordan,
Morocco, Spain, Canary Island, Eastern Africa Congo, South Africa etc.
Cultivation and market value:
Mainly cultivated in Madhya Pradesh and Rajasthan and the varieties
cultivated are Jawahar Asgandh-20, Jawahar Asgandh-134 and Rakshita.
The cultivation of Ashwagandha does not need much
attention and labour. The crop is grown even on soil
which is unsuited for other crops. The propagation method is direct sowing of
seeds (broadcasting) and planting time is June to September. No special
preparation or cure of the land is required to plant this crop. The crop is
mainly grown on residual fertility. Hence, no fertilizers applied. However,
addition of nitrogenous fertilizers such as ammonium sulphate
produces plants with heavy leaf growth and small roots. No irrigation is given
throughout the growing period. Excessive rainfall is harmful because it leads
to extensive weed growth. Major disease is damping off, seedling rotting, and
seedling blight. Seed treatment with Captan 3 gm/kg
of seeds is recommended. The plants produce flower and fruit in December and
January. Hence the crop is ready in six months and harvesting starts from
January and continues up to last March. A yield of 300-400 kg roots/hector in
addition to 50-75 kg seeds/hector obtained at the end of six months. It has
huge internal consumption in India and also being exported.
Plant pathology
Withania somnifera is prone to
several pests and diseases.
1.Leaf spot
disease caused by Alternaria alternata is the most prevalent disease, which is
most severe in the plains of Punjab, Haryana, and Himachal Pradesh. Bio-deterioration
of its pharmaceutically active components during leaf spot disease has been
reported2.
2.The Choanephora cucurbitarum causes a stem and leaf rot of Withania somnifera3.
3.A treehopper,
feeds on the apical portions of the stem, making them rough and woody in
appearance and brown in colour. The apical leaves are
shed and the plant gradually dies4.
4.The carmine red
spider mite (Tetranychus urticae) is
the most prevalent pest of the plant in India5.
Ayurvedic properties:
Rasa- Tikta, Kasaya,
Madhura, Guna- Snigdha, Laghu, Virya- Usna, Vipaka-
Madhura, Doshakarma- Kapha Vata Samaka
Chemical ingredients-
Steroidal alkaloids and lactones known as withanolides
specifically Withaferin A and Withanolide
D are two main withanolides contribute to the most of
the biological actions of withania. Withanine, Withaniol, Anaferin, Tropine and many other
Alkaloids and Steroids are present.
Medicinal uses in Ayurveda:
Useful part of Ashwagandha is mainly the root.
Seeds, leaves and fruits are also used as medicine.
External Uses: Ashwagandha leaves and
root paste is applied on enlarged cervical glands or swelling of other glands
as it reduces oedema and pain, oil massage is done in
vata diseases and weakness. In ear discharge the
juice of Ashwagandha leaves is used as eardrops. For
healing of blisters, black ashes of the roots are applied. The dried leaves are
ground to a powder from which a paste is made and used in the treatment of
burns and wounds and also for a sunscreen upon women's faces.
Internal uses:
Nervous system: Ashwagandha root is
sedative, tranquilizing and nervine tonic, hence
helps in tonic nerves and useful in fainting, giddiness and insomnia (The
species name somnifera means
"sleep-inducing" in Latin) 6. It is also used as an “adaptogen” to help the body cope with daily stress, as a
general tonic and for improving thinking ability. It also improves the brain’s
memory functions like attention and concentration, hence helping with the
symptoms of Parkinson’s, Alzheimer’s and other neuro-degenerative
diseases. It enables the body to reserve and sustain vital energy throughout
the day while promoting sound, peaceful sleep at night. Ashwagandha
benefits, strengthens and tones all muscle tissues including the heart and
lungs. It increases muscle tone while concurrently
soothing muscular inflammation. It is an ideal remedy for muscular
aches, pains, and stiffness, weakness and low body weight.
Digestive system: The bark powder of Ashwagandha
is appetizer, carminative and anthelmintic and hence
is used in abdominal pain, constipation and worms.
Circulatory system: Ashwagandha has an
effect on the heart, purifies the blood and reduces oedema.
So it is used in weakness of heart, blood disorders and oedema.
The decoction is used in rheumatoid arthritis.
Respiratory system: Ashwagandha is an
expectorant and has anti asthmatic property, due to which it is useful in
cough. Ashwagandha ash along with ghee and honey is
effective in asthma. If phlegm is thin, it is used in the form of ash or its
alkaline extract is used. Decoction of bark should be given in low dose for
cough and asthma. It is also used as a tonic in the above conditions.
Reproductive system: Ashwagandha is considered as sukrala
i.e. semenogogue which increases semen. It is well
known for its aphrodisiac property and is used in semen disorders. A mixture of
5 gms of Ashwagandha
powder, 10 gms of ghee and sugar along with 250 ml
milk is a good tonic, nutritious and aphrodisiac. It completely cures puerperal
backache and leucorrhoea caused due to endometritis.
Urinary system: It is a diuretic and used in oliguria
or anurea.
Skin: Ashwagandhadi churna
is indicated in wrinkle skin and premature ageing and premature graying of
hair. It is used in vitiligo and other skin diseases.
Satmilkaran: It increases
weight, improves immunity and is an aphrodisiac. Used in debilitation diseases
and marasmus in children.
Medicines in market: Ashwagandhadi Churna, Balarista, Ashwagandha Rasayana, Ashwagandha Ghrit, Ashwagandharishta, Dhatupoustika Churna, Phala Kalyan
Ghrita, Rasaraj Rasa etc.
Side effects and contraindications: Ashwagandha
is not recommended in case of hyperthyroidism or pregnancy and can in high
doses provoke certain intestinal problems. In strong doses, Ashwagandha
can have a hypnotic effect. Hence should be started with small doses then
increased gradually. Ashwagandha is best taken in the
evening, because in strong doses the plant can act as a sedative.
Pharmacological evidences:
1.Anti inflammatory property:
The
alcoholic extract has significant anti-inflammatory property in both acute and
chronic types of inflammation. The decoction of root on oral administration
against carrageenin induced inflammation, produced
marked anti inflammatory property7. The extract of leaves on
experimental models of sub acute models of inflammation and CCl4
induced hepatotoxicity in albino rats exhibited anti
inflammatory effect8. Ashwagandha
possessed marked anti-inflammatory effect against denaturation
of protein in vitro. The effect was plausibly due to the alkaloid and withanolide contents of Ashwagandha9.
2.Hepatoprotective activity: Alcoholic extract of the
leaves of the plant was found to significantly inhibit CCl4 induced
alterations in transaminase activity and pentobarbitone sleeping time indicating presence of hepatoprotective activity. This was confirmed through histopathological studies10.
3.Infertility
activity: Roots have infertility activity in mice and did not completely abolish oestrus or mating but it delayed the processes. Roots have
also effect to produce infertility mating and caused decreased in litter size,
tuber roots have no uterine stimulant activity on isolated guinea pig uterus11.
4.Anti bacterial activity: The leaves
exhibited anti-bacterial and anti fungal property. It was effective against
gram positive bacteria and Helminthosporium sativum (fungus) 12.
5.Psychotropic/Anti anxiety
activity: Total alcoholic extract on oral administration in albino rats caused
decreased locomotor activity and learning behavior,
potentiated barbiturate hypnosis, increase in the whole brain tissue level of
serotonin and histamine. It induced depletion of catecholamines
and Ach in the brain13. The
aqueous suspensions of roots of Ashwagandha and the
Korean drug Ginseng were tested comparatively for 2 pharmacological activities,
namely Anti-stress activity by the ‘mice swimming endurance test’ and anabolic
activity by noting gain in body weights and levator ani muscle in rats showed a significant increase in mice
swimming time by Ginseng and Ashwagandha as compared
to the control group. Significant increase in body weights in the Ashwagandha treated group was better than Ginseng. Gain in
wet weights of the levator ani
muscle were also significant in Ginseng and Ashwagandha
treated groups, however, the weight gain of dried levator
ani muscles showed comparable results for both these
drugs 14.
6.Anti convulsant
activity: Dried powder, decoction and alcoholic extract showed anti convulsant property against electro shock and phenobarbitone, the alchoholic
extract being much more potent 15.
7.Skin care: Its potent
antioxidant properties help protect the skin against free radical damage and
slow down the ageing process by firming up the skin for a more youthful look. Ashwagandha stimulates DHEA, which is a precursor to both
testosterone and estrogen and stimulates the production of natural skin oils.
It also promotes the production of vital compounds and proteins for healthy
skin such as hyaluronan for skin hydration, elastin to keep the skin supple and collagen for skin
strength. For glowing skin Ashwagandha can be used as
a toner with dried ginger and lemon.
8.Healthy Hair: Used in
shampoos, Ashwagandha is believed to help improve
scalp circulation and strengthen the hair, as well as help get rid of dandruff.
It also appears to stimulate production of melanin, the pigment responsible for
the colour of hair. So, it may actually reverse
graying of hair and it also helps deal with hair loss.
9.Immuno-modulator
activity: Ashwagandha has shown a significant
modulation of immune reactivity in animal models. Administration of Ashwagandha was found activity like immunosuppressive
drugs, viz, cyclophosphamide,
azathioprin and prednosolone.
Treatment with Ashwagandha was found to significantly
increase Hb concentration, RBC count, platelet count,
and body weight in mice16. Administration of asgandh
extract was found to significantly reduce leucopenia induced by cyclophosphamide (CTX) treatment. Administration of Asgand extract increase the number of CTX treated animals,
compared to the CTX alone treated group 17. Administration of asgand extract was found significantly reduce leucopenia
induced sub lethal dose of gamma radiation 18.
10.Anti peroxidative
action: The importance of Withania somnifera root extract in the regulation of lead toxicity
with special reference to lipid peroxidative process
has been investigated in liver and kidney tissues. While lead treatment (0.5
mg/kg body wt. / day for 20 days) enhanced hepatic and renal lipid peroxidation (LPO), administration of plant extract in the
doses of 0.7 g/kg and 1.4 g/kg body wt. / day along with equivalent doses of
lead acetate for 20 days significantly decreased LPO and increased the
activities of antioxidant enzymes, viz., superoxide dismutase (SOD) and catalase (CAT), thus retaining normal peroxidative
status of the tissues. It was suggested that the ameliorating role of root
extract of W. somnifera in the lead intoxicated mice
could be the result of its antiperoxidative action 19.
11.Anti ageing effect: Double blind
clinical trial carried out to study the effect of plant on prevention of ageing
in 101 normal healthy males in 50-59 years age group. Root powder (0.5gm) was
given orally three times a day for 1 year. Results showed statistically
significant increase in Hb%, RBC, hair melanin, and
seated stature in treated group in comparison to placebo group. Decrease in
serum cholesterol was more in treated group than in placebo group 20.
12.Macrophage activating
effect: The chemotactic activity of macrophages and
production of Interleukin-1 (IL-1) and tumor necrosis factor (TNF) were
significantly reduced in mice treated with the carcinogen achratoxin
A (OTA). Administration of Ashwagandha with other
drugs was found to significantly inhibit OTA-induced suppression of macrophage chemotaxis and production of IL-1 and TNF-α
by macrophages 21.
13.Haemopoitic effect: The combination
of Ashwagandha and ginseng (Panax
ginseng) was orally administered in rats for 90 days using three doses. There
was significant increase in body weight, food consumption and liver weight and
improved haemopoisis was observed 22.
14.Antibiotic Activity: The antibiotic
activity of the Ashwagandha roots as well as leaves
experimentally shown that Withaferin A in
concentration of 10µg/ml inhibited the growth of various Gram-positive
bacteria, acid-fast and aerobic bacilli, and pathogenic fungi. It was active
against Micrococcus pyogenes var
aureus and partially inhibited the activity of Bacillus
subtilis glucose-6-phosphate-dehydrogenase. Withaferin A inhibited Ranikhet
virus. The shrub’s extract is active against Vaccinia
virus and Entamoeba histolytica 23-25.
Asgand showed the protective action against systemic Aspergillus infection. This protective activity was
probably related to the activation of the macrophage function revealed by the
observed increases in phagocytosis and intracellular
killing of peritoneal macrophages induced by Ashwagandha
treatment in mice 26. Antibiotic activity of Withaferin
A is due to the presence of the unsaturated lactone-ring.
The lactone showed strong therapeutic activity in
experimentally induced abscesses in rabbits, being somewhat stronger than that
of Penicillin. It substantiates the reputation of the leaves as a cure for
ulcers and carbuncles in the indigenous system of medicine 27.
15.Anti-tumour
Activity: Withaferin A, withanolide
D and E exhibited significant antitumour activity in
vitro against cells derived from human epidermoid
carcinoma of nasopharynx (KB) and in vivo against
Ehrlich ascites carcinoma, Sarcoma 180, Sarcoma Black
(SBL), and E 0771 mammary adenocarcinoma in mice in
doses of 10,12, 15 mg/kg body weight. Growth of Ehrlich ascites
carcinoma was completely inhibited in more than half the mice which survived
for 100 days without the evidence of growth of the tumour.
They also acted as a mitotic poison arresting the division of cultured human
larynx carcinoma cells at metaphase and in HeLa cultures
similar to star metaphase. Withaferin A caused
mitotic arrest in embryonic chicken fibroblast cells. Methylthiodeacetyl
colchicines potentiated the effect of Withaferin A.
the presence of an unsaturated lactone in the
side-chain to which an allelic primary alcohol group is attached at C25 and the
highly oxygenated rings at the other end of the molecule may well suggest
specific chemical systems possessing carcinostatic properties28-30. Withaferin A has been shown to possess growth inhibitory
and radio-sensitizing effects on experimental mouse tumours31.
Administration of Withaferin A in mice inoculated
with Ehrlich ascites carcinoma cells was found to
inhibit tumour growth and increase tumour-free animal survival in a dose dependent manner32,33.
The alcoholic extract of the dried roots of the plant as well as the active
component Withaferin A isolated from the extract
showed significant antitumour and radio-sensitizing
effects in experimental tumours in vivo, without any
noticeable systemic toxicity. One hour treatment with Withaferin
A in a non-toxic dose of 2.1 µM before irradiation significantly enhanced cell
killing. Withaferin A gave a sensitizer enhancement
ratio (SER) of 1.5 for in vitro cell killing of V79 Chinese hamster cells at a
non-toxic concentration of approximately 2 µM. SER increased with drug dose 32,
33.
16.Anti-hyperglycemic Effect: Asgand along with other ingredients of a composite formulation (Transina) have been reported to decrease streptozocin (STZ) induced hyperglycemia in rats. This
anti-hyperglycemic effect may be due to pancreatic islet free radical
scavenging activity because the hyperglycemic activity of STZ is a consequence
of decrease in pancreatic islet cell superoxide dismutase (SOD) activity
leading to the accumulation of degenerative oxidative free radicals in
islet-beta cells 34.
17.Morphine
Tolerance and Dependence-Inhibiting Effect: Repeated administration of Asgand in mice attenuated the development of tolerance to
the analgesic effect of morphine. Asgand also suppressed
morphine-withdrawal jumps, a sign of the development of morphine dependence35.
Administration of glycol-withanolides of Withania somnifera
was found to suppress morphine-induced inhibition of intestinal motility and to
attenuate the development of tolerance to the analgesic effect of morphine in
mice 36.
18.Cardio tonic
Activity: The constituents of withania structurally
being similar to digoxin are demonstrated to exhibit cardiotonic activity and provide a salutary effect in CHF 37.
19.Hypolipidemic and Anti-Atherogenic
Activity: Withania has profound hypocholesteremic, hypolipidemic and anti-atherogenic
activity. The anti-atherogenic activity of Caps HT2,
a botanical medicine comprising of several plants including W. somnifera against vascular intimal
damage and atherogenesis which leads to various types
of cardiovascular diseases was demonstrated. The formulation scavenges free
radicals, inhibited lipid peroxidation, delayed the
plasma re-calcification time and enhanced the release of lipoprotein lipase
enzyme. It also inhibited platelet aggregation comparable to heparin. The
formulation altered atherogenic index and reduced the
body weight with rise of high density lipoprotein cholesterol levels in hyperlipidemic rats. In a clinical study and herbal
cocktail containing withania used as an adjunct to
conventional anti-ischemic drugs has been found to reduce total cholesterol,
triglycerides and increase high density lipoprotein cholesterol in the post
myocardial infarction patients. The hypolipidemic and
antiatherogenic potential is an additional benefit of
its usefulness in cardiovascular diseases38-41.
20.Positive Inotropic Activity: Withania
has been reported to reduce blood pressure due to autonomic ganglion blocking
action and myocardial depressant effects as well as positive inotropic and chronotropic
effects 41. The alkaloids had a prolonged hypotensive,
bradycardiac and respiratory-stimulant action 42.
21.Hypoglycemic Effect: Hyperglycemia
is a major risk factor of cardiovascular diseases. Withania
favorably alters blood and urine glucose levels, glycated
hemoglobin and liver enzymes in diabetic rats 38, 43.
22.Anti-oxidant activity: Some of the
chemicals found in Withania somnifera are powerful antioxidants. Studies conducted
on rats’ brains showed the herb produced an increase in the levels of three
natural antioxidants-superoxide dismutase, catalase
and glutathione peroxidase44. These findings are consistent
with the therapeutic use of Withania somnifera as an Ayurvedic rasayana. The antioxidant effect of active principles of Withania somnifera root
may explain the reported anti-stress, cognition-facilitation, anti-inflammatory
and anti-aging effects produced by them in experimental animals, and in
clinical situations 45.
23.Anti-carcinogenic activity:
Ashwagandha is reported to have
anti-carcinogenic effects. Research on animal cell cultures has shown that the
herb decreases the levels of the nuclear factor kappa B, suppressed the
intercellular tumor necrosis factor, and potentiates apoptotic signaling in
cancerous cell lines 46. One of the most exciting of the possible
uses of Ashwagandha is its capacity to fight cancers
by reducing tumor size 47. To investigate its use in treating
various forms of cancer, the antitumor effects of Withania
somnifera have been studied by researchers. In
one study, the herb was evaluated for its anti-tumor effect in urethane-induced
lung tumors in adult male mice. Following administration of Ashwagandha
over a period of seven months, the histological appearance of lungs of animals
which received the herb was similar to those observed in the lungs of control
animals 48.
CONCLUSION:
Withania somnifera (Linn) Dunal commonly
known as Ashwagandha in Ayurveda
medicine possesses numerous pharmacological activities supported by experimental
and clinical studies. Further studies will enhance the support of its
multifarious action on living organisms.
REFERENCES:
1.
Atal, C.K., and Schwarting, A.E., Ashwagandha-An Ancient Indian Drug, Economic Botany,15,
256-263 (1961).
2.
Pati, P. K.; Sharma, M., Salar, R. K., Sharma, A.,
Gupta, A. P., Singh, B. (2009). "Studies on leaf spot disease of Withania somnifera and
its impact on secondary metabolites". Indian Journal of Microbiology 48
(4): 432–437.
3.
Saroj, A., Kumar, A., Qamar, N., Alam, M., Singh, H. N., Khaliq,
A. (2012). "First report of wet rot of Withania somnifera caused by Choanephora cucurbitarum in India". Plant Disease 96 (2): 293.
4.
Sharma, A., Pati, P. K. (2011). "First report of Withania somnifera
(L.) Dunal, as a New Host of Cowbug
(Oxyrachis tarandus, Fab.) In Plains of Punjab, Northern India". World
Applied Sciences Journal 14 (9): 1344–1346.
5.
Sharma, A., Pati, P. K. (2012). "First record of the carmine
spider mite, Tetranychus urticae,
infesting Withania somnifera in
India". Journal of Insect Science 12 (50): 1.
6.
Stearn, W. T. (1995). Botanical Latin: History, Grammar, Syntax, Terminology
and Vocabulary (4th ed.). Timber Press.
7.
Sharma, A K, and Singh,
R.H.: Screening of anti inflammatory activity of certain indigenous drugs on carageenin induced hind paw oedma
in rats, Bull.Medico-Ethno-Bot.Res1 (2): 262-71, 1980.
8.
Sudhir, S., Budhiraja, R.D., Moglani,
G.P. Arora, B., Gupta, L.C. and Garg, K. N. : Planta Med., 1986, No.1, 61.
9.
Sangita Chandra et al, Evaluation of
Anti-inflammatory Effect of Ashwagandha: A
Preliminary Study in vitro, Pharmacognosy Journal, Volume 4, Issue 29,
May–June 2012, Pages 47–49.
10. Sudhir,
S., Budhiraja, R.D., Moglani,
G.P. Arora, B., Gupta, L.C. and Garg,
K. N.: Planta Med., 1986, No.1, 61.
11. Parasar,G
C, Thesis of M. VSc. (Pharmacology) degree, Vikram University, Ujjain, 1963.
12. Bhatnagar,
S et al: Biological activity of Indian Medicinal plants, Part-I, Antibacterial,
anti tubercular and anti fungal action, Indian J.Med.Res.
49 (5): 799-813, 1961.
13. Singh, R H et.al: Study on the
psychotropic effect of Indian indigenous drug Ashwagandha
(W. somnifera),
Part-II, Experimental studies, J. Res. Indian Med, Yoga and Homoeo,
14 (1): 49-54, 1979.
14. Anuradha
Grandhi et al, A comparative pharmacological
investigation of Ashwagandha and Ginseng, Journal of Ethnopharmacology, Volume 44, Issue 3, December 1994, Pages
131–135.
15. Rai,
NP et al, experimental studies on an indigenous drug Withania somnifera Dunal
in electrical induced convulsions in albino rats, Nagarjun,
28 (3):7-9, 1984.
16. Ziauddin
et, al., Studies on the immunomodulatory effect of Asgandh, J. Ethnopharmacol, 1996;
50 (2)): 69-76.
17. Davis,L
et al, Supressive effect of cyclophosphamide-induced
toxicity by Withania somnifera
extract in mice, J. Ethnopharmacology, 1998; 62 (3):
209-214.
18. Kutta,G
Use of Withania somnifera Dunal as an adjuvant during radiation therapy, Indian J Exp
Biol. 1996; 34(9): 854-856.
19. Shyam
Sunder Chaurasia et al, Withania somnifera root extract in the regulation
of lead-induced oxidative damage in male mouse, Pharmacological Research,
Volume 41, Issue 6, June 2000, Pages 663–666.
20. Rastogi
et.al., Compendium of Indian Medicinal Plants, 2nd reprint, Central
Drug Research Institute, Lucknow and National
Institute of Science Communication, Council of Scientific and industrial
Research, New Delhi, 1998.
21. Dhule,
J N, Effect of some Indian herbs on macrophage functions in Ochratoxin
A treated mice, J. Ethnopharmacol, 1997, 589 (1),
15-20.
22. Aphale
AA et al, Sub acute toxicity study of the combination of Ginseng (Panax ginseng) and Ashwagandha
(Withania somnifera)
in rats: A safety assessment, 1998.
23. Anonymous, The Wealth of
India. Vol. X ( Sp-W), Publications and Information Directorate, Council of
Scientific and Industrial research (CSIR), New Delhi (1982) 580-585.
24. Rastogi
RP and Mehrotra BN, Compendium of Indian Medicinal
Plants. 2nd Reprint, Central Drug Research Institute, Lucknow and National Institute of Science Communication,
Council of Scientific and Industrial Research, New Delhi (1998) Vol. 1:
434-436; Vol. 2: 708-710; Vol. 3: 682-684; Vol. 4: 765-766; vol. 5: 889-891;
Vol. 6: 148.
25. Khare
CP, Indian Medicinal Plants- An Illustrated Dictionary, First Indian Reprint,
Springer (India) Pvt. Ltd. New Delhi (2007) 717-718.
26. Dhuley
J N, Effect of Asgand on lipid peroxidation
in stress induced animals, J Ethnopharmacol, 1998; 7
(2): 173-178.
27. Anonymous, The Wealth of India,
Vol. X (Sp-W), Publications and Information Directorate, Council of Scientific
and Industrial research (CSIR), New Delhi (1982) 580-585.
28. Anonymous, The Wealth of
India, Vol. X ( Sp-W), Publications and Information Directorate, Council of
Scientific and Industrial research (CSIR), New Delhi (1982) 580-585.
29. Rastogi
RP and Mehrotra BN, Compendium of Indian Medicinal
Plants. 2nd Reprint, Central Drug Research Institute, Lucknow and National Institute of Science Communication,
Council of Scientific and Industrial Research, New Delhi (1998) Vol. 1:
434-436; Vol. 2: 708-710; Vol. 3: 682-684; Vol. 4: 765-766; vol. 5: 889-891;
Vol. 6: 148.
30. Khare
CP, Indian Medicinal Plants- An Illustrated Dictionary. First Indian Reprint,
Springer (India) Pvt. Ltd. New Delhi (2007) 717-718.
31. Ganasoundary
A, Zare S.M., Devi P.U., Modification of bone marrow radiosensitivity by medicinal plant extracts, British
journal of Radiology, 1997; 70 (834): 599-602.
32. Devi P.U., Sharad
A.C., Soloman F. E. In vivo growth inhibitory and
radio-sensitizing effects of Withaferin A on mouse
Ehrlich ascites acarcinoma.
Cancer Letters. 1995;95 (1-2): 189-193.
33. Sharada
A.C., Solomon F.E., Devi P,U., Udupa N., Srinivasan K.K. Antitumour and radiosensitizing effects of withaferin
A on mouse Ehrlich ascites carcinoma in vivo. Acta, Oncoloty, 1996; 35 (1):
95-100).
34. Bhattacharya S.K., Satyan K.S., Chakrabati A. Effect
of Transina (TR), an Ayurvedic
herbal formulation, on pancreatic islet superoxide dismutase (SOD) activity in
hyperglycemic rats. Indian J Exp Biol. 1997; 35 (3): 297-299.
35. Kulkarni
S.K., Ninan I., Inhibition of morphine tolerance and
dependence by Withania somnifera
in mice. J Ethnopharmacol. 1997; 57(3): 213-217.
36. Rao
P.R., Rao K.T., Srivastava
R.S., Ghosal S. Effect of glycowithanolieds
from Withania somnifera
on morphine-induced inhibition of intestinal motility and tolerance of analegesia in mice. Phytotherapy
Res. 1995; 9(1):66-68.
37. Das, P.K., C.L. Malhotra and K. Prasad, 1964, Cardiotonic
activity of ashwagandhine and ashwagandinine,
two alkaloids from Withania, Kaul
Arch Int Pharmacodyn Ther., 150: 356-62.
38. Andallu,
B. And B. Radhika, 2000, Hypoglycemic, diuretic and hypocholesterolemic effect of winter cherry (Withania somnifera, Dunal) root, Indian J. Exp. Bil.,
38: 607-9.
39. Mary, N.K., B.H. Babu and J. Padikkala, 2003,
Anti-atherogenic effect of Caps HT2, an herbal Ayurvedic medicine formulation. Phytomedicine,
10: 474-82.
40. Dwivedi,
S., G. Deepti and D.K. Sharma, 2000, Modification of
coronary risk factors by medicinal plants. J. Med. Aroma. Plant Sci., 22: 616-620.
41. Budhiraja,
R.D., S. Sudhir and K.N. Garg,
1983, Cardiovascular effects of a withanolide from Withania coagulans Dunal fruits. Indian J. Physiol. Pharmacol.,
27: 129-34].
42. Malhotra,
C.L., P.K. Das, N.S. Dhalla and K. Prasad, 1981.
Studies on Withania ashwagandh, Kaul. III. The effect of total alkaloids on the
cardiovascular system and respiration. Indian J. Med. Res., 49: 448-460.
43. Udayakumar,
R., S. Kasthurirengan, T.S. Mariashibuy
M. Rajesh, V.R. Anbazhagan, S.C. Kim, Aganapathi and C.W. Choi, 2009, Hypoglycamemic and hypolipidaemic
effects of Withania somnifera
root and leaf extracts on alloxan-induced
diabetic rats. Int. J. Mol. Sci., 10: 2367-82.
44. Dhuley
UN; J Ethnopharmacol, 2007, 57-63.
45. Bone K; Clinical Applications
of Ayurvedic and Chinese Herbs. Queensland,
Australia: Phytotherapy Press, 1996, 137-41.
46. Ichikawa H; Takada Y; Shishodia S; Jayaprakasam B; Nair
MG; Aggrawal BB. Molecular Cancer Therapeutics, 2006,
1434-45.
47. Prakash
J; Gupta SK; Dinda AK; Nutr
Cancer 2002, 42, 91-97, Jayaprakasam B; Zhang Y; Seeram N; Nair M. Life Sci 2003,
74, 125-132.
48. Singh N; Singh SPL Nath R; et al. International Journal Crude Drug
Research, 1986, 24, 90-100.
Received on
19.01.2016 Modified
on 27.01.2016
Accepted on
21.02.2016 ©A&V Publications All right reserved
Res. J.
Pharmacology & P’dynamics. 8(1): Jan.-Mar., 2016;
Page 23-29
DOI: 10.5958/2321-5836.2016.00006.9